Buy Vyvanse 70 mg Online
Vyvanse is used in the treatment of binge eating disorder; Adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Vyvanse 70 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Common side effects of Vyvanse include: insomnia and irritability. Other side effects include: dizziness, weight loss, and xerostomia. See below for a comprehensive list of adverse effects.
Use of CNS stimulants (amphetamines and methylphenidate-containing products), including lisdexamfetamine dimesylate, have a high potential for abuse and dependence. Assess the risk of abuse before prescribing and monitor for signs of abuse and dependence during therapy.
General Instructions for Use
Take VYVANSE by mouth in the morning with or without food; avoid afternoon doses because of the potential for insomnia. VYVANSE may be administered in one of the following ways:
Information for VYVANSE capsules:
- Swallow VYVANSE capsules whole, or
- Open capsules, empty and mix the entire contents with yogurt, water, or orange juice. If the contents of the capsule include any compacted powder, a spoon may be used to break apart the powder. The contents should be mixed until completely dispersed. Consume the entire mixture immediately. It should not be stored. The active ingredient dissolves completely once dispersed; however, a film containing the inactive ingredients may remain in the glass or container once the mixture is consumed.
Information for VYVANSE chewable tablets:
- VYVANSE chewable tablets must be chewed thoroughly before swallowing.
VYVANSE capsules can be substituted with VYVANSE chewable tablets on a unit per unit/ mg per mg basis (for example, 30 mg capsules for 30 mg chewable tablet).
Do not take anything less than one capsule or chewable tablet per day. A single dose should not be divided.
Dosage for Treatment of ADHD
The recommended starting dose is 30 mg once daily in the morning in patients ages 6 and above. Dosage may be adjusted in increments of 10 mg or 20 mg at approximately weekly intervals up to maximum dose of 70 mg/day
Dosage for Treatment of Moderate to Severe BED in Adults
The recommended starting dose is 30 mg/day to be titrated in increments of 20 mg at approximately weekly intervals to achieve the recommended target dose of 50 to 70 mg/day. The maximum dose is 70 mg/day. Discontinue VYVANSE if binge eating does not improve.
Dosage in Patients with Renal Impairment
In patients with severe renal impairment (GFR 15 to < 30 mL/min/1.73 m2), the maximum dose should not exceed 50 mg/day. In patients with end stage renal disease (ESRD, GFR < 15 mL/min/1.73 m2), the maximum recommended dose is 30 mg/day Dosage Modifications due to Drug Interactions
Agents that alter urinary pH can impact urinary excretion and alter blood levels of amphetamine. Acidifying agents (e.g., ascorbic acid) decrease blood levels, while alkalinizing agents (e.g., sodium bicarbonate) increase blood levels. Adjust VYVANSE dosage accordingly
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Buy vyvanse 70 mg online